EP Patent

EP2651399A2 — Controlled release dosage forms

Assigned to Purdue Pharma LP · Expires 2013-10-23 · 13y expired

What this patent protects

Dosage forms having a core having a surface having means for controlling release(s) on an active agent(s); methods of manufacturing, tools used in manufacturing; and uses of the dosage forms are described.

USPTO Abstract

Dosage forms having a core having a surface having means for controlling release(s) on an active agent(s); methods of manufacturing, tools used in manufacturing; and uses of the dosage forms are described.

Drugs covered by this patent

pyridostigmine-bromide (PYRIDOSTIGMINE BROMIDE)

Patent Metadata

Patent number: EP2651399A2
Jurisdiction: EP
Classification: —
Expires: 2013-10-23
Drug substance claim: No
Drug product claim: No
Assignee: Purdue Pharma LP
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.